Clinical trial Recruiting at 1 site Interventional Ages 16 to 40

Houston Hospital-Based Violence Intervention Program to prevent repeat firearm injuries

Official title: Launching the Houston-HVIP: Developing and Evaluating a Hospital-Based Intervention to Reduce Recurrent Violence

Run by The University of Texas Health Science Center, Houston · NCT06263647 · Data updated 2026-11-12

This project will test whether a hospital-based violence intervention (Houston-HVIP) can reduce repeat firearm injuries and improve mental, behavioral, and physical health over 12 months in people ages 16–35 treated for gunshot wounds.

Quick facts

Study typeInterventional
Ages16 Years to 40 Years
SexAll
Enrollment274 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedSeptember 16, 2025
Main results expectedFebruary 1, 2028
Study endsMay 31, 2028
Registry record updatedOctober 16, 2026
Trial IDNCT06263647 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English- or Spanish-speaking people aged 16–35 who live in Harris County and present to Memorial Hermann Hospital with a gunshot injury from community violence and can give voluntary consent.

Probably not a fit

Patients whose injuries were self-inflicted or accidental, those who are actively detained, or people who do not live in Harris County or cannot consent are unlikely to qualify or benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll patients aged 16–35 who present to Memorial Hermann Hospital with gunshot injuries from community violence and who live in Harris County. Participants who consent and speak English or Spanish will be randomly assigned to receive the Houston-HVIP intervention or standard of care. The study will track violent reinjury and a range of behavioral, mental health, and physical recovery outcomes over a 12-month follow-up. Exclusions include self-inflicted or unintentional firearm injuries and patients actively detained by the criminal justice system at enrollment.

Why it matters

Potential benefit: If successful, the program could lower the chance of repeat firearm injury and support better mental and physical recovery after a violent injury.

How similar studies have gone: Similar hospital-based violence intervention programs have shown promising reductions in repeat injury and related harms in several prior trials, although results vary by setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* presented for a gunshot injury stemming from community violence at Memorial Hermann Hospital
* English or Spanish-speaking
* provide informed voluntary consent to participate in the study
* live in Harris County at time of enrollment
* live within 40-mile radius of Memorial Hermann Hospital- Texas Medical Center

Exclusion Criteria:

* presenting for a firearm injury arising from a self-inflicted gunshot or unintentional gun violence
* actively detained by criminal justice systems at time of enrollment

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Sandra McKay, MD — The University of Texas Health Science Center, Houston
  • Study coordinator: Sandra McKay, MD
  • Email: Sandra.McKay@uth.tmc.edu
  • Phone: (713) 500-5666

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.